Transgenic plants as bioreactors of pharmaceuticals recombinant proteins. | Vestnik Tomskogo gosudarstvennogo universiteta. Biologiya - Tomsk State University Journal of Biology. 2012. № 2 (18).

Transgenic plants as bioreactors of pharmaceuticals recombinant proteins.

This review describes recent advances in the use of genetically modified plants for production of recombinant proteins for pharmaceutical use. Emphasis on the benefits of use the expression of genetically modified plants compared to other systems. In the specific examples discussed in forward-looking plant expression systems for production of recombinant proteins. The current state of the market of recombinant proteins using transgenic plants. The prospects of creating "edible" vaccines that are based on genetically modified plants.

Download file

Counter downloads: 236

Keywords

"edible" vaccines, bioprodutsenty, recombinant proteins, «съедобные» вакцины, transgenic plants, рекомбинантные белки, биопродуценты, трансгенные растения

Authors

Name	Organization	E-mail
Deineko Elena V.	Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences, Novosibirsk	deineko@bionet.nsc.ru

Всего: 1

References

Tacket C.O., Mason H.S., Losonsky G., Estes M.K., Arntzen C.J. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes // J. Infectious Diseases. 2000. Vol. 182. P. 302-305.

Schelkunov S.N., Salyaev R.K., Pozdnyakov S.G. et al. Immunogenecity of a novel, bivalent, plantbased oral vaccine against hepatitis B and human immunodeficiency viruses // Biotechnology Letters. 2006. Vol. 28, № 13. P. 959-967.

Arakawa T., Chong D.K.X., Langridge H.R. Efficacy of food plant-based oral cholera toxin B sununit vaccine // Nature Biotechnology. 1998. Vol. 16. P. 292-297.

Mason H.S., Haq T.A., Clements J.D., Arntzen C.J. Edible vaccine protects mice against Echerichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B-gene // Vaccine. 1998. Vol. 16. P. 1336-1343.

Haq T.A., Mason H.S., Clements J.D., Arntzen C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants // Science. 1995. Vol. 268. P. 714-719.

Mason H.S., Lam D.M., Arntzen C.J. Expression of hepatitis B surface antigen in transgenic plants // Proceedings of the National Academy of Sciences of the United States of America. 1992. Vol. 89. P. 11745-11749.

Apeler H., Peters J., Schroder W. Expression, purification, biochemical and pharmacological characterization of a recombinant aprotinin variant // Drug Res. 2004. Vol. 54, № 8. P. 483-497.

Tiwari S., Verma P.C., Singh P.K., Tuli R. Plants as bioreactors for the production of vaccines and antigens // Biotechnology Advances. 2009. Vol. 27. P. 449-467.

Lienard D., Tran Ding O., van Oort M. Suspension-culture BY-2 tobacco cells produce and mature immunologically active house dust mite allergens // Plant Biotechnology J. 2007. Vol. 5. P. 93-108.

Hellwig S., Drossard J., Fisher R. Plant cell culture for the production of recombinant proteins // Nature Biotechnology. 2004. Vol. 22. P. 1415-1422.

Franklin S.E., Mayfield S.P. Prospects for molecular farming in the green algae Chlamydomonas // Current Opinion in Plant Biology. 2004. Vol. 7. P. 159-165.

Merchant S.S., Prochnik S.E., Vallon O. The Chlamydomonas genome reveals the evolution of key animal and plant functions // Science. 2007. Vol. 318, № 5848. P. 245-250.

Leon-Banares R., Gonzalez-Ballester D., Galvan A., Fernandez E. Trasnsgenic algae as green cell-factories // Trends Biotechnology. 2004. Vol. 22. P. 45-52.

Boynton J.E., Gilham N.W., Harris S.E. Chloroplast transformation in Chlamydomonas with high velocity microprojectiles // Science. 1988. Vol. 240. P. 1534-1538.

Franklin S.E., Mayfield S.P. Expression of human antibodies in eukaryotic micro-algae // Vaccine. 2005. Vol. 23. P. 1928-1832.

Weise A., Altmann F.M., Rodriguez-Franco M. High level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella delta-fuc-t and delta-xyl-t mutant // Plant Biotechnology J. 2007. Vol. 5. P. 389-401.

Koprivova A., Stemmer C., Altmann F. Targeted knockouts of Physcomitrella lacking plantspecific immunogenic N-glyvans // Plant Biotechnology J. 2004. Vol. 2. P. 517-523.

Fischer R., Twyman R.M., Schillberg S. Production of antibodies in plants and their use for global health // Vaccine. 2003. Vol. 21. P. 821-825.

Cox K.M., Sterling J.D., Regan J.T. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor // Nature Biotechnology. 2006. Vol. 24. P. 1591-1597.

Reinsing S., Lang D., Knight C. The Physcomitrella Genome Evolutionary Insights into Land by Plants // Science. 2008. Vol. 319. P. 64-69.

Schaefer D., Zryd J.P., Knight C.D., Cove D.J. Stable transformation of the moss Physcomitrella patens // Molecular and General Genetics. 1991. Vol. 226. P. 418-424.

Gasdaska J.R., Spencer D., Dickey L.F. Advantages of therapeutic protein production in the aquatic plant Lemna // Bioprocessing J. 2003. Vol. 3. P. 50-56.

Lelivelt C., McCabe M., Newell C. Stable plastid transformation in lettuce (Lactuca sativa L.) // Plant Molecular Biology. 2005. Vol. 58. P. 763-774.

Yusibov V., Streatfield S., Kushnir N. Clinical development of plant-produced recombinant pharmaceuticls // Human Vaccines. 2011. Vol. 7, № 3. P. 313-321.

Tecson Mendoza E.M., C.L.A. et al. Recent advances in the development of transgenic papaya technology // Biotechnology Annual Review. 2008. Vol. 14. P. 423-462.

Penney C., Thomas D., Deen S., Walmsley A. Plant-made vaccines in support of the Millenium Development Goals // Plant Cell Reports. 2011. Vol. 30. P. 789-798.

DeCosa B., Moar W., Lee S.B. Hyper-expression of the Bt Cry-2 Aa2 operon in chloroplast leads to formation of insecticidal crystals // Nature Biotechnology. 2001. Vol. 19. P. 71-74.

Dufourmantel N., Tiscot G., Goutorbe F. Generation of fertile transplastomic soybean // Plant Molecular Biology. 2004. Vol. 55. P. 479-489.

Kumar S., Daniel H. Transgenic containment by maternal inheritance: effective or elusive // Proceedings of the National Academy of Sciences of the United States of America. 2007. Vol. 1104. P. 6879-6880.

Yusibov V., Rabindran S. Resent progress in the development of plant-derived vaccines // Expert Reviews of Vaccines. 2008. Vol. 7. P. 1173-1183.

Rybiski E.P. Plant-produced vaccines: promise and reality // Drug Discovery Today. 2008. Vol. 13. P. 894-901.

Paul M., Dolleweerd C., Drake P., Ma J. Molecular pharming: Future targets and aspirations // Human Vaccines. 2011. Vol. 7, № 3. P. 375-382.

Parvaiz A., Muhammad A., Muhammad Y. et al. Role of transgenic plants in agriculture and biopharming // Biotechnology Advances. 2012. Vol. 30. P. 524-540.

Obeme O., Popoola J., Leelavathi S., Reddy S. Advances in plant molecular farming // Biotechnology Advances. 2011. Vol. 29. P. 210-222.

Paul M., Ma J. Plant-made pharmaceuticals: Leading products and production platforms // International Union of Biochemistry and Molecular Biology, Inc. 2011. Vol. 58, № 1. P. 58-67.

Martinez 2 C.A., Guilietti A.M., Talou R. Research advances in plant-made flavi-virus antigens // Biotechnology Advances. 2012. Doi:10.1016/j.biotechadv.2012.03.004.

Sourrouille C., Marshall B., Lienard D., Faye L. From Neanderthal to Nanobiotech: From Plant Potions to Pharming with Plant Factories. In Book: Methods in Molecular Biology: Recombinant Proteins From Plants / ed. by L. Faye, V. Gomord. Humana Press, a part of Springer Science+Buisness Media, 2009. P. 1-23.

Peuke A.D., Rennenberg H. Phytoremediation with transgenic trees // Z. Naturforsch. 2005. Bd. 60, № 3/4. S. 199-207.

Fischer R., Schilberg S., Helliwig S. et al. GMP issues for recombinant plant-derived pharmaceuticalsd proteins // Biotechnology Advances. 2012. Vol. 30. P. 434-439.

Campbell M., Fitzgerald H., Ronald P. Engineering pathogen resistance in crop plants // Transgenic Research. 2002. Vol. 11. P. 599-613.

Potricus I. Golden rice and beyond // Plant Physiology. 2001. Vol. 125, № 3. Р. 1157-1161.

Peuke A.D. Rennenberg H. Phytoremediation // EMBO Rep. 2005. Vol. 6. P. 497-501.

Clemente T.E., La Vallee B.J., Howe A.R. et al. Progeny analysis of glyphosate selected transgenic soybean derived from Agrobacterium-mediated transformation // Crop Science. 2000. № 40. P. 797-803.